Skip to main content

Tracking the Host Response to Infection in Peritoneal Models of Acute Resolving Inflammation

  • Protocol
  • First Online:
Inflammation and Cancer

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2691))

  • 787 Accesses

Abstract

Antimicrobial host defense is dependent on the rapid recruitment of inflammatory cells to the site of infection, the elimination of invading pathogens, and the efficient resolution of inflammation that minimizes damage to the host. The peritoneal cavity provides an accessible and physiologically relevant system where the delicate balance of these processes may be studied. Here, we describe murine models of peritoneal inflammation that enable studies of competent antimicrobial immunity and inflammation-associated tissue damage as a consequence of recurrent bacterial challenge. The inflammatory hallmarks of these models reflect the clinical and molecular features of peritonitis seen in renal failure patients on peritoneal dialysis. The development of these models relies on the preparation of a cell-free supernatant derived from an isolate of Staphylococcus epidermidis (termed SES). Intraperitoneal administration of SES induces a Toll-like receptor 2-driven acute inflammatory response that is characterized by an initial transient influx of neutrophils that are replaced by a more sustained recruitment of mononuclear cells and lymphocytes. Adaptation of this model using a repeated administration of SES allows investigations into the development of adaptive immunity and the hallmarks associated with tissue remodelling and fibrosis. These models are therefore clinically relevant and provide exciting opportunities to study innate and adaptive immunity and the response of the stromal tissue compartment to bacterial infection and the ensuing inflammatory reaction.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hurst SM, Wilkinson TS, McLoughlin RM et al (2001) Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 14:705–714

    Article  CAS  PubMed  Google Scholar 

  2. Fielding CA, McLoughlin RM, McLeod L et al (2008) IL-6 regulates neutrophil trafficking during acute inflammation via STAT3. J Immunol 181:2189–2195

    Article  CAS  PubMed  Google Scholar 

  3. McLoughlin RM, Hurst SM, Nowell MA et al (2004) Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms. J Immunol 172:5676–5683

    Article  CAS  PubMed  Google Scholar 

  4. McLoughlin RM, Jenkins BJ, Grail G et al (2005) IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation. Proc Natl Acad Sci USA 102:9589–9594

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. McLoughlin RM, Witowski J, Robson RL et al (2003) Interplay between IFN-gamma and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation. J Clin Invest 112:598–607

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Hams E, Colmont CS, Dioszeghy V et al (2008) Oncostatin M receptor-beta signaling limits monocytic cell recruitment in acute inflammation. J Immunol 181:2174–2180

    Article  CAS  PubMed  Google Scholar 

  7. Jones GW, McLoughlin RM, Hammond VJ et al (2010) Loss of CD4+ T cell IL-6R expression during inflammation underlines a role for IL-6 trans signaling in the local maintenance of Th17 cells. J Immunol 184:2130–2139

    Article  CAS  PubMed  Google Scholar 

  8. Nowell MA, Richards PJ, Horiuchi S et al (2003) Soluble IL-6 receptor governs IL-6 activity in experimental arthritis: blockade of arthritis severity by soluble glycoprotein 130. J Immunol 171:3202–3209

    Article  CAS  PubMed  Google Scholar 

  9. Richards PJ, Nowell MA, Horiuchi S et al (2006) Functional characterization of a soluble gp130 isoform and its therapeutic capacity in an experimental model of inflammatory arthritis. Arthritis Rheum 54:1662–1672

    Article  CAS  PubMed  Google Scholar 

  10. Nowell MA, Williams AS, Carty SA et al (2009) Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis. J Immunol 182:613–622

    Article  CAS  PubMed  Google Scholar 

  11. Jones GW, Greenhill CG, Williams JO et al (2013) Exacerbated inflammatory arthritis in response to hyperactive gp130 signalling is independent of IL-17A. Ann Rheum Dis 72:1738–1742

    Article  CAS  PubMed  Google Scholar 

  12. Fielding CA, Jones GW, McLoughlin RM et al (2014) Interleukin-6 signaling drives fibrosis in unresolved inflammation. Immunity 40:40–50

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Jones SA (2005) Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol 175:3463–3468

    Article  CAS  PubMed  Google Scholar 

  14. Jenkins BJ, Grail D, Nheu T et al (2005) Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling. Nat Med 11:845–852

    Article  CAS  PubMed  Google Scholar 

  15. Colmont CS, Raby AC, Dioszeghy V et al (2011) Human peritoneal mesothelial cells respond to bacterial ligands through a specific subset of toll-like receptors. Nephrol Dial Transplant 26:4079–4090

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Strunk T, Power Coombs MR, Currie AJ et al (2010) TLR2 mediates recognition of live Staphylococcus epidermidis and clearance of bacteremia. PLoS One 5:e10111

    Article  PubMed  PubMed Central  Google Scholar 

  17. Liao CT, Rosas M, Davies LC et al (2016) IL-10 differentially controls the infiltration of inflammatory macrophages and antigen-presenting cells during inflammation. Eur J Immunol 46:2222–2232

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Raby AC, Le Bouder E, Colmont C et al (2009) Soluble TLR2 reduces inflammation without compromising bacterial clearance by disrupting TLR2 triggering. J Immunol 183:506–517

    Article  CAS  PubMed  Google Scholar 

  19. Raby AC, Holst B, Le Bouder E et al (2013) Targeting the TLR co-receptor CD14 with TLR2-derived peptides modulates immune responses to pathogens. Sci Transl Med 5:185ra64

    Article  PubMed  Google Scholar 

  20. Raby AC, Colmont CS, Kift-Morgan A et al (2017) Toll-like receptors 2 and 4 are potential therapeutic targets in peritoneal dialysis-associated fibrosis. J Am Soc Nephrol 28:461–478

    Article  CAS  PubMed  Google Scholar 

  21. Morgan AH, Dioszeghy V, Maskrey BH et al (2009) Phosphatidylethanolamine-esterified eicosanoids in the mouse: tissue localization and inflammation-dependent formation in Th-2 disease. J Biol Chem 284:21185–21191

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Simon A. Jones .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Millrine, D., Rice, C.M., Fernandez, J.U., Jones, S.A. (2023). Tracking the Host Response to Infection in Peritoneal Models of Acute Resolving Inflammation. In: Jenkins, B.J. (eds) Inflammation and Cancer. Methods in Molecular Biology, vol 2691. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3331-1_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-3331-1_7

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-3330-4

  • Online ISBN: 978-1-0716-3331-1

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics